Asia Pacific Pharmacogenomics Market

Asia Pharmacogenomics Market By Technology (Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others), By Application (Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others), By End User (Hospitals and Clinics, Research Institutions, and Academic Institutes)

Report Id: KBV-2538 Publication Date: June-2019 Number of Pages: 103
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Asia Pacific Pharmacogenomics Market would witness market growth of 10.2% CAGR during the forecast period (2019-2025). The study of pharmacogenomics deals with the role of genes in drug response in individuals. The growing number of pharmacogenomics-based tests, which are a result of the growing ailments like cancer, tuberculosis, Alzheimer's disease, cardiovascular diseases, and other diseases, is expected to push the market growth. Pharmacogenomics has observed an exponential growth rate in recent years, owing to a rise in preference of patients towards personalized therapy-based medications.

The major factors boosting the growth of pharmacogenomics include technological advancements in molecular diagnostics, such as several molecular biology techniques including polymerase chain reaction, sequencing, microarrays, electrophoresis, mass spectrometry among others, a surge in the preference for using personalized therapy.

Based on Technology, the market is segmented into Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others. Based on Application, the market is segmented into Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others. Based on End User, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Click Here For Free Insights

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.

Scope of the Pharmacogenomics Market Analysis

Market Segmentation:

By Technology

  • Sequencing
  • Polymerase Chain Reaction
  • Electrophoresis
  • Mass Spectrometry
  • Microarray
  • Others

By Application

  • Oncology
  • Psychiatry
  • Infectious Diseases
  • Neurological Diseases
  • Pain management
  • Cardiovascular Diseases
  • Others

By End User

  • Hospitals and Clinics
  • Research Institutions
  • Academic Institutes

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Abbott Laboratories
  • Empire Genomics LLC
  • Illumina, Inc.
  • OneOme LLC
  • Myriad Genetics Inc.
  • Thermo Fisher Scientific, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Bayer AG
  • Opko Health, Inc.
  • Becton, Dickinson and Company
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo